The education of the next generation of cancer researchers is essential to our progress in the prevention, detection, diagnosis, and treatment of cancer. This application seeks renewal of funding for the Tumor Biology Interdisciplinary Training Program that has been funded by NCI since 1996. Our program is the premier graduate and postdoctoral training program at Georgetown University Medical Center (GUMC). Its major focus is to provide pre-doctoral and postdoctoral trainees with lifelong interdisciplinar skills that will enable them to make significant contributions in the eradication of human cancer and to interact productively in their future with clinical cancer research programs. The program is structurally integrated with the strengths of the NCI- designated, Lombardi Comprehensive Cancer Center (LCCC) at GUMC. LCCC provides a stimulating environment for the program with interdisciplinary collaborations, extensive core facilities to support research, and a forum fr communication and discussion of research. State-of-the-art cancer research training is available in the laboratories of the participating faculty. Courses, workshops, seminars, journal clubs, research fairs, and special interest group meetings contribute to the distinctly interdisciplinary training for pre- and postdoctoral fellows. Our faculty has developed more than a dozen cancer-related courses that integrate core concepts of cancer biology, clinical disease, bioinformatics as well as emerging research technologies, and health disparities. Exposure to clinical concepts is emphasized through courses, involvement in weekly clinical conferences, and seminars that focus on translational cancer research. The program has continuously attracted outstanding applicants and thus all available slots are filled annually. Many of our past trainees have gone on to prestigious research positions. Our program emphasizes recruitment of underrepresented minorities (URM) and a significant number of our URM trainees are now in faculty positions in academia. The continued support of this Program will allow us to maintain our mission to train the next generation of researchers that contribute to the eradication of cancer.

Public Health Relevance

The education of the next generation of cancer researchers is essential to our progress in the prevention, detection, diagnosis, and treatment of cancer. This application seeks renewal of funding for the Tumor Biology Interdisciplinary Training Program at Georgetown University Medical Center (GUMC). Its major focus is to provide pre-doctoral and postdoctoral trainees with lifelong interdisciplinary skills that will enable them to make significnt contributions in the eradication of human cancer and to interact productively in their future with clinical cancer research programs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
2T32CA009686-18
Application #
8664063
Study Section
Subcommittee G - Education (NCI)
Program Officer
Damico, Mark W
Project Start
1996-07-01
Project End
2019-05-31
Budget Start
2014-06-10
Budget End
2015-05-31
Support Year
18
Fiscal Year
2014
Total Cost
$471,850
Indirect Cost
$33,604
Name
Georgetown University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Lelo, Alana; Prip, Frederik; Harris, Brent T et al. (2018) STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle-Invasive Bladder Cancer. Clin Cancer Res 24:4145-4153
Stires, Hillary; Heckler, Mary M; Fu, Xiaoyong et al. (2018) Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities. Mol Cell Endocrinol 471:105-117
Vera, Nicholas B; Chen, Zhidan; Pannkuk, Evan et al. (2018) Differential mobility spectrometry (DMS) reveals the elevation of urinary acetylcarnitine in non-human primates (NHPs) exposed to radiation. J Mass Spectrom 53:548-559
Ory, Virginie; Kietzman, William B; Boeckelman, Jacob et al. (2018) The PPAR? agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ. Breast Cancer Res Treat 169:47-57
Tiek, D M; Rone, J D; Graham, G T et al. (2018) Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma. Sci Rep 8:7222
Tassi, Elena; Lai, En Yin; Li, Lingli et al. (2018) Blood Pressure Control by a Secreted FGFBP1 (Fibroblast Growth Factor-Binding Protein). Hypertension 71:160-167
Speidell, Andrew P; Demby, Tamar; Lee, Yichien et al. (2018) Development of a Human APOE Knock-in Mouse Model for Study of Cognitive Function After Cancer Chemotherapy. Neurotox Res :
Pannkuk, Evan L; Laiakis, Evagelia C; Fornace Jr, Albert J et al. (2018) A Metabolomic Serum Signature from Nonhuman Primates Treated with a Radiation Countermeasure, Gamma-tocotrienol, and Exposed to Ionizing Radiation. Health Phys 115:3-11
Nomura, Sarah J O; Dash, Chiranjeev; Sheppard, Vanessa B et al. (2017) Sedentary time and postmenopausal breast cancer incidence. Cancer Causes Control 28:1405-1416
Hilakivi-Clarke, Leena; Wärri, Anni; Bouker, Kerrie B et al. (2017) Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical Model. J Natl Cancer Inst 109:

Showing the most recent 10 out of 214 publications